within Pharmacolibrary.Drugs.D_Dermatologicals.D10A_AntiAcnePreparationsForTopicalUse.D10AA01_Fluorometholone;

model Fluorometholone
  extends Pharmacolibrary.Drugs.ATC.D.D10AA01
  // parameters inherited from base class, duplicate, uncomment and change if necesarry
  /*
  
    weight         = 70,
    F              = 1,
    Cl             = 1.5555555555555556e-06,
    adminDuration  = 600,
    adminMass      = 0.1 / 1000000,
    adminCount     = 1,
    Vd             = 0.0005,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01  
  */
  ;

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Fluorometholone</td></tr><tr><td>ATC code:</td><td>D10AA01</td></tr><td>route:</td><td>ophthalmic</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>0.1</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>0.5</td><td>L</td></tr>
    <tr><td>clearance:</td><td>0.08</td><td>L/h/kg</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Fluorometholone is a synthetic corticosteroid with anti-inflammatory properties, mainly used as an ophthalmic agent to treat inflammatory conditions of the eye, such as allergic conjunctivitis and postoperative inflammation. It is approved for use today in eye drops and ointments.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic data for fluorometholone systemic exposure in humans appears to exist; pharmacokinetic parameters are estimated based on corticosteroid class and ophthalmic use.</p><h4>References</h4><ol></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Fluorometholone;
